Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.43 USD | -0.29% | -6.79% | +106.63% |
30/05 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
07/05 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+106.63% | 33Cr | |
+11.91% | 12TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
-17.47% | 1.56TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- ADC Therapeutics' : Chief Medical Officer Resigns; Replacment named